Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PMS2P9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NPC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TBCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP128 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM96B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BSG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5J2-PTCD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTTG1IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTN2A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASA4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OGT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHODH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STARD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC12A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on